Skip to content

Reference Values for Gastric Emptying

Normal Values for Gastric Emptying in a 13C-octanoate Breath Test Using a Solid Test Meal

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02397577
Acronym
13C
Enrollment
75
Registered
2015-03-25
Start date
2015-02-28
Completion date
2018-05-01
Last updated
2018-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed Gastric Emptying

Brief summary

Healthy volunteers will ingest a 13C-octaoate containing test meal and 13C in expiratory air will be followed. Normal values will be calculated data of these tests.

Detailed description

This is a clinical study for establishing reference values in a 13C-octanoate breath test and a 13C-sodium acetate breath test. Healthy volunteers (n=75) will eat a solid test meal of scrambled eggs and toast containing 13C-octanoate. 13C-content of exhaled air will be measured at baseline and followed for the next 4 hours. One week later, the healthy volunteers (n=75) will drink a standardized nutritional shake (Ensure Plus Vanille, Abbott) containing 13C-sodium acetate. 13C-content of exhaled air will be measured at baseline and for the next 4 hours. Estimated gastric emptying time will be calculated using established algorithms.

Interventions

OTHERSolid test meal, liquid test meal on two separate occations

13C labeld solid test meal, 13C labeld liquid test meal on two separate occations

Sponsors

University of Bern
CollaboratorOTHER
University of Zurich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects free of relevant abdominal complaints * Written informed consent

Exclusion criteria

* Age under 18 * Previous history of gastrointestinal disease or surgery (excludes appendectomy, hernia repair and anorectal disorders) * Known diabetes mellitus, scleroderma, neurological impairment or other major current disease * Subjects unable to stop medication that alters gut function for 1 week prior to the study, including anticholinergics, calcium canal inhibitors, beta blocker, prokinetics, proton-pump inhibitors, DDV-IV-Inhibitors, Inkretin-mimetica, non-steroidal anti-inflammatory drugs, macrolid antibiotics * Pregnancy beyond week 12 (no pregnancy test will be performed) * Involvement in any other clinical trial during the course of this trial, nor within a period of 14 days prior to its beginning or 14 days after its completion * Known allergy or intolerance against hen egg protein or gluten

Design outcomes

Primary

MeasureTime frame
Half gastric emptying time t50 according to Ghoos et al. (t50_Ghoos)4 hours after test meal

Secondary

MeasureTime frame
t50 according to Bluck & Coward (t50_Bluck)4 hours after test meal
t50 according to Wagner & Nelson (t50_WN)4 hours after test meal
Gastric emptying coefficient (GEC)4 hours after test meal

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026